BJ
CHRS icon

BlackRock Japan’s Coherus Oncology CHRS Stock Holding History

BlackRock Japan’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1K Sell
22
-911
-98% -$25.5K ﹤0.01% 1303
2016
Q3 		$25K Buy
933
+509
+120% +$13.9K ﹤0.01% 1087
2016
Q2 		$7K Sell
424
-109
-20% -$2.05K ﹤0.01% 1306
2016
Q1 		$11K Sell
533
-4,062
-88% -$66.5K ﹤0.01% 1270
2015
Q4 		$106K Sell
4,595
-209
-4% -$5.38K ﹤0.01% 897
2015
Q3 		$96K Sell
4,804
-10,442
-68% -$318K ﹤0.01% 871
2015
Q2 		$441K Buy
+15,246
New +$385K ﹤0.01% 796

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return